Comprehensive Cancer Center designated by the National Cancer Institute


In the News

Dr. Weisdorf

Minneapolis, MN – Daniel J. Weisdorf, MD, Professor of Medicine and Deputy Director, University of Minnesota Clinical and Translational Institute, received the 2020 Charles Bolles Bolles-Rogers Award by the Twin Cities Medical Society Foundation (TCMSF). Joseph Cardamone, MD, TCMSF Board of Directors, along with Charles Ryan, MD, Director, Division of Hematology, Oncology and Transplantation, University of Minnesota, presented the award on Wednesday, October 14, 2020.

Deepali Sachdev, PhD, a breast cancer researcher with the Masonic Cancer Center and the University of Minnesota Medical School, was recently awarded a research grant by METAvivor. 

- Presented by 2019 NYFW + #Cancerland in memory of Champagne Joy - Deepali Sachdev, BSc,MSc, PhD  Regents University - Development of natural killer cell based tri-specific killer engagers (TriKEs) as novel immunotherapy for metastatic breast cancer - 

Rein In Sarcoma Logo

Rein in Sarcoma proudly announces a $150,000 research grant approved by the Rein in Sarcoma Board on January 27, 2020. This brings the cummulative research funding by Rein in Sarcoma to $2 million since the organization’s founding in 2001. All proposals were reviewed though a central electronic review system and had three external reviewers for each proposal following NIH scoring procedures. Based on their review and the UMN Faculty recommendations, the RIS Research Task Force brought forward three proposals for RIS Board approval.


Newswise — ROCHESTER, Minn. — A statewide bipartisan initiative is transforming health care from a focus on treating disease to one of tapping the body's ability to heal itself. Regenerative Medicine Minnesota is a legislative initiative aimed at improving health by advancing regenerative medicine in research, technology, education and patient care across the state.

Clark Chen
The University of Minnesota is testing an experimental treatment, and that's giving one cancer patient hope. See full story at the link below.

MOCA celebrated 20 years of progress – and new milestones in ovarian cancer research funding – at the MOCA Annual Meeting this week.

This year, MOCA awarded $680,000 in funding to Minnesota and national researchers, putting our total amount of funding at nearly $9 million.

The 2019 MOCA-funded researchers at the Masonic Cancer Center, University of Minnesota include: